11.01.2023 • News

Azelis Acquires Benelux Distributor Smoky Light

Specialty chemicals and food ingredients distributor Azelis has acquired 100% of Benelux smoke ingredients distributor Smoky Light.

The company said the acquisition reinforces its position in the Benelux market and expands its footprint in the smoke ingredient market of EMEA.

Smoky Light’s product portfolio, Azelis added, strategically complements the Antwerp, Belgium-based group’s lateral value chain for the food & nutrition market, thereby further expanding its expertise and product offering to customers.

Established in 1995 and located in Reeuwijk, the Netherlands, Smoky Light specializes in smoke, grill, browning agents and cooking flavors and additives and additionally has its own formulation laboratory. Following the deal’s closing, Ahrend Buckers will continue to lead the business and support the integration into Azelis.

Thanks to Azelis’strong infrastructure in the market, Buckers said his company will be able to enter a wider smoke ingredients industry.  Evy Hellinckx, managing director Azelis Benelux, added that integrating Smoky Light will reinforce Azelis’ footprint in the Netherlands and Belgium and also further strengthen Azelis' expertise and activities in smoke ingredients, building on its growth strategy.

Author: Dede Williams, Freelance Journalist

Company

Logo:

Azelis Corporate Services NV

12 box 6, Posthofbrug
2600 Antwerpen
Belgium

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read